Menu Search
Equities

Shanghai MicroPort MedBot Group Co Ltd

2252:HKG.HZ

Shanghai MicroPort MedBot Group Co Ltd

Actions
  • Price (HKD)6.81
  • Today's Change0.08 / 1.19%
  • Shares traded1.34m
  • 1 Year change-67.02%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai MicroPort MedBot Group Co Ltd is a China-based company primarily engaged in the provision of intelligent surgery total solutions. The Company’s main business is engaged in the research and development, manufacturing and sale of surgical robots. The Company’s products include Toumai Laparoscopic Surgical Robot, Skywalker Orthopedic Surgical Robot, R-one vascular intervention surgical robot, Microport Medbot and other products, covering surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)112.91m
  • Net income in HKD-1.09bn
  • Incorporated2015
  • Employees650.00
  • Location
    Shanghai MicroPort MedBot Group Co LtdRoom 101, Area B, Building 1601 Zhangdong Road, China (Shanghai)Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
  • Phone+86 2 138954600
  • Websitehttps://www.medbotsurgical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.